150 related articles for article (PubMed ID: 37981525)
1. Genomics, Transcriptomics, and Epigenetics of Sporadic Pituitary Tumors.
Marrero-Rodríguez D; Vela-Patiño S; Martinez-Mendoza F; Valenzuela-Perez A; Peña-Martínez E; Cano-Zaragoza A; Kerbel J; Andonegui-Elguera S; Glick-Betech SS; Hermoso-Mier KX; Mercado-Medrez S; Moscona-Nissan A; Taniguchi-Ponciano K; Mercado M
Arch Med Res; 2023 Dec; 54(8):102915. PubMed ID: 37981525
[TBL] [Abstract][Full Text] [Related]
2. Integrating Methylome and Transcriptome Signatures Expands the Molecular Classification of the Pituitary Tumors.
Silva-Júnior RMPD; Bueno AC; Martins CS; Coelli-Lacchini F; Ozaki JGO; Almeida-E-Silva DC; Marrero-Gutiérrez J; Santos ACD; Garcia-Peral C; Machado HR; Santos MVD; Elias PL; Moreira AC; Colli LM; Vêncio RZN; Antonini SR; de Castro M
J Clin Endocrinol Metab; 2023 May; 108(6):1452-1463. PubMed ID: 36504388
[TBL] [Abstract][Full Text] [Related]
3. A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone--an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture.
Matsuno A; Sasaki T; Mochizuki T; Fujimaki T; Sanno N; Osamura Y; Teramoto A; Kirino T
Acta Neurochir (Wien); 1996; 138(8):1002-7. PubMed ID: 8890999
[TBL] [Abstract][Full Text] [Related]
4. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
[TBL] [Abstract][Full Text] [Related]
5. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
[TBL] [Abstract][Full Text] [Related]
6. The Genomic Landscape of Corticotroph Tumors: From Silent Adenomas to ACTH-Secreting Carcinomas.
Andonegui-Elguera S; Silva-Román G; Peña-Martínez E; Taniguchi-Ponciano K; Vela-Patiño S; Remba-Shapiro I; Gómez-Apo E; Espinosa-de-Los-Monteros AL; Portocarrero-Ortiz LA; Guinto G; Moreno-Jimenez S; Chavez-Macias L; Saucedo R; Basurto-Acevedo L; Lopez-Felix B; Gonzalez-Torres C; Gaytan-Cervantes J; Ayala-Sumuano JT; Burak-Leipuner A; Marrero-Rodríguez D; Mercado M
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563252
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
8. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
9. The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive Subtypes.
Salomon MP; Wang X; Marzese DM; Hsu SC; Nelson N; Zhang X; Matsuba C; Takasumi Y; Ballesteros-Merino C; Fox BA; Barkhoudarian G; Kelly DF; Hoon DSB
Clin Cancer Res; 2018 Sep; 24(17):4126-4136. PubMed ID: 30084836
[No Abstract] [Full Text] [Related]
10. The molecular biology of sporadic acromegaly.
Marrero-Rodríguez D; Moscona-Nissan A; Sidauy-Adissi J; Haidenberg-David F; Jonguitud-Zumaya E; de Jesus Chávez-Vera L; Martinez-Mendoza F; Taniguchi-Ponciano K; Mercado M
Best Pract Res Clin Endocrinol Metab; 2024 May; 38(3):101895. PubMed ID: 38641464
[TBL] [Abstract][Full Text] [Related]
11. Genomic and molecular characterization of pituitary adenoma pathogenesis: review and translational opportunities.
Elsarrag M; Patel PD; Chatrath A; Taylor D; Jane JA
Neurosurg Focus; 2020 Jun; 48(6):E11. PubMed ID: 32480367
[TBL] [Abstract][Full Text] [Related]
12. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.
Yamada S; Takahashi M; Hara M; Hattori A; Sano T; Ozawa Y; Shishiba Y; Hirata K; Usui M
Clin Endocrinol (Oxf); 1996 Sep; 45(3):263-72. PubMed ID: 8949563
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemistry of four mixed pituitary adenomas and intrasellar gangliocytomas associated with different clinical syndromes: acromegaly, amenorrhea-galactorrhea, Cushing's disease and isolated tumoral syndrome.
Li JY; Racadot O; Kujas M; Kouadri M; Peillon F; Racadot J
Acta Neuropathol; 1989; 77(3):320-8. PubMed ID: 2922994
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin receptor subtypes mRNA in TSH-secreting pituitary adenomas: a case showing a dramatic reduction in tumor size during short octreotide treatment.
Horiguchi K; Yamada M; Umezawa R; Satoh T; Hashimoto K; Tosaka M; Yamada S; Mori M
Endocr J; 2007 Jun; 54(3):371-8. PubMed ID: 17420609
[TBL] [Abstract][Full Text] [Related]
15. Galectin-3 Expression in Functioning and Silent ACTH-Producing Adenomas.
Jin L; Riss D; Ruebel K; Kajita S; Scheithauer BW; Horvath E; Kovacs K; Lloyd RV
Endocr Pathol; 2005; 16(2):107-14. PubMed ID: 16199895
[TBL] [Abstract][Full Text] [Related]
16. Clinical characterization of familial isolated pituitary adenomas.
Daly AF; Jaffrain-Rea ML; Ciccarelli A; Valdes-Socin H; Rohmer V; Tamburrano G; Borson-Chazot C; Estour B; Ciccarelli E; Brue T; Ferolla P; Emy P; Colao A; De Menis E; Lecomte P; Penfornis F; Delemer B; Bertherat J; Wémeau JL; De Herder W; Archambeaud F; Stevenaert A; Calender A; Murat A; Cavagnini F; Beckers A
J Clin Endocrinol Metab; 2006 Sep; 91(9):3316-23. PubMed ID: 16787992
[TBL] [Abstract][Full Text] [Related]
17. Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcription-polymerase chain reaction.
Evans CO; Young AN; Brown MR; Brat DJ; Parks JS; Neish AS; Oyesiku NM
J Clin Endocrinol Metab; 2001 Jul; 86(7):3097-107. PubMed ID: 11443173
[TBL] [Abstract][Full Text] [Related]
18. N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma.
Vaitkiene P; Valiulyte I; Glebauskiene B; Liutkeviciene R
Diagn Pathol; 2017 Apr; 12(1):33. PubMed ID: 28390436
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and analysis in 1385 Chinese patients with pituitary adenomas.
Shao S; Li X
J Neurosurg Sci; 2013 Sep; 57(3):267-75. PubMed ID: 23877272
[TBL] [Abstract][Full Text] [Related]
20. Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas.
Jameson JL; Klibanski A; Black PM; Zervas NT; Lindell CM; Hsu DW; Ridgway EC; Habener JF
J Clin Invest; 1987 Nov; 80(5):1472-8. PubMed ID: 2824561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
